Self-Management of Oral Anticoagulation Therapy Improves Long-Term Survival in Patients With Mechanical Heart Valve Replacement

Annals of Thoracic Surgery

Volumn 83, Issue 1, 2007, Pages 24-29

  Koertke, Heinrich ^a   Zittermann, Armin ^a   Wagner, Otto ^a   Koerfer, Reiner ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

ACUTE HEART FAILURE; ADULT; AGE; AGED; ANTICOAGULANT THERAPY; ARTICLE; BODY MASS; BRAIN HEMORRHAGE; CARDIOGENIC SHOCK; CARDIOMYOPATHY; CAUSE OF DEATH; CORONARY ARTERY BYPASS GRAFT; EMBOLISM; FEMALE; FOLLOW UP; GENERAL PRACTITIONER; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART INFARCTION; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HEART VENTRICLE FIBRILLATION; HUMAN; HYPERTENSION; INTERNATIONAL NORMALIZED RATIO; INTESTINAL BLEEDING; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SAINT JUDE HEART VALVE PROSTHESIS; SELF CARE; SMOKING; STATISTICAL ANALYSIS; STROKE; SURVIVAL TIME;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; FEMALE; FOLLOW-UP STUDIES; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; SELF CARE;

EID: 33845476726     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2006.08.036     Document Type: Article

References (21)

1. Mühlhauser I., and Berger M. Diabetes education and insulin therapy. When will they ever learn?. J Intern Med 233 (1993) 321-326
2. Sawicki P.T., Muhlhauser I., Didjurgeit U., Baumgartner A., Bender R., and Berger M. Intensified antihypertensive therapy is associated with improved survival in type I diabetic patients with nephropathy. J Hypertens 13 (1995) 933-938
3. Koertke H., Zittermann A., Mommertz S., El-Arousy M., Litmatzhe J., and Koerfer R. The Bad Oeynhausen concept of INR self-management. J Thromb Thrombolysis 19 (2005) 25-31
4. White R.H., McCurdy S.A., von Marendorff H., Woodruff D.E., and Leftgoff L. Home prothrombin time monitoring after the initiation of warfarin therapy. Ann Int Med 111 (1989) 730-737
5. Sawicki P. A structured teaching and self-management program for patients receiving oral anticoagulation. JAMA 281 (1999) 145-150
6. Cromheecke M.E., Levi M., Colly L.P., et al. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison. Lancet 356 (2000) 97-102
7. Watzke H.H., Forberg E., Svolba G., Jimenez-Boj E., and Krinniger B. A prospective controlled trial comparing weekly self-testing and self-dosing with the standard management of patients on stable oral anticoagulation. Thromb Haemost 83 (2000) 661-665
8. Christensen T.D., Andersen N.T., Attermann J., Hjortdal V.E., Maegaard M., and Hasenkam J.M. Mechanical heart valve patients can manage oral anticoagulation therapy themselves. Eur J Cardiothorac Surg 23 (2003) 292-298
9. Körtke H., and Körfer R. International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous?. Ann Thorac Surg 72 (2001) 44-48
10. Körtke H., Minami K., Breymann T., et al. INR self-management after mechanical heart valve replacement: ESCAT (Early Self-Controlled Anticoagulation Trial). Z Kardiol 90 suppl 6 (2001) 118-124
11. Cen Y.Y., Glower D.D., Landolfo K., et al. Comparison of survival after mitral valve replacement with biologic and mechanical valves in 1139 patients. J Thorac Cardiovasc Surg 122 (2001) 569-577
12. Parker D.J. Long-term morbidity and mortality after aortic and mitral valve replacement with tissue valves and certification to fly. Eur Heart J 9 suppl G (1988) 153-157
13. Chesebro J.H., and Fuster V. Antithrombotic therapy for acute myocardial infarction: mechanisms and prevention of deep venous, left ventricular, and coronary artery thromboembolism. Circulation 74 (1986) III1-III10
14. Vink R., Kraaijenhagen R.A., Hutten B.A., et al. The optimal intensity of vitamin K antagonists in patients with mechanical heart valves: a meta-analysis. J Am Coll Cardiol 42 (2003) 2042-2048
15. Stein P.D., Alpert J.S., Bussey H.I., Pharm D., Dalen J.E., and Turpie G.G. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves. Chest 119 suppl 1 (2001) 220S-7
16. Oden A., and Fahlen M. Oral anticoagulation and risk of death: a medical record linkage study. Br Med J 325 (2002) 1073-1075
17. Koertke H., Zittermann A., Minami K., et al. Low-dose international normalized ratio self-management: a promising tool to achieve low complication rates after mechanical heart valve replacement. Ann Thorac Surg 79 (2005) 1909-1914
18. Borel M.L., Amaral A., Bezon E., et al. Evaluation de la mortalite et de la qualite de vie postoperatoire des sujets de plus de 75 ans apres remplacement valvulaire pour retrecissement aortique. A propos de 110 cas. Arch Mal Coeur Vaiss 96 (2003) 967-972
19. Torn M., Bollen W.L.E.M., van der Meer F.J.M., van der Wall E.E., and Rosendaal F.R. Risks of oral anticoagulation therapy with increasing age. Arch Intern Med 165 (2005) 1527-1532
20. Minami K., Zittermann A., Schulte-Eistrup S., Koertke K., and Körfer R. Mitroflow synergy prostheses for aortic valve replacement: 19 years experience with 1,516 patients. Ann Thorac Surg 80 (2005) 1699-1705
21. Eitz T., Fritzsche D., Kleikamp G., Zittermann A., Horstkotte D., and Körfer R. Reoperation of the aortic valve in octogenarians. Ann Thorac Surg 82 (2006) 1385-1391